IRIS
RUSCITTI, PIERO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.995
AS - Asia 4.683
EU - Europa 4.021
SA - Sud America 700
AF - Africa 82
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 10
Totale 17.503
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.870
SG - Singapore 2.431
IE - Irlanda 1.394
CN - Cina 932
BR - Brasile 623
RU - Federazione Russa 622
HK - Hong Kong 584
IT - Italia 399
DE - Germania 375
SE - Svezia 358
TR - Turchia 320
UA - Ucraina 226
GB - Regno Unito 194
VN - Vietnam 137
FI - Finlandia 128
FR - Francia 90
IN - India 77
CA - Canada 68
BE - Belgio 45
JP - Giappone 41
MX - Messico 38
ZA - Sudafrica 38
AR - Argentina 30
BD - Bangladesh 30
PL - Polonia 30
NL - Olanda 29
LT - Lituania 25
CZ - Repubblica Ceca 23
ES - Italia 23
ID - Indonesia 21
EC - Ecuador 14
IQ - Iraq 13
AT - Austria 12
EU - Europa 9
PK - Pakistan 9
SA - Arabia Saudita 9
VE - Venezuela 9
AE - Emirati Arabi Uniti 8
CH - Svizzera 8
GR - Grecia 8
JO - Giordania 8
UZ - Uzbekistan 8
AZ - Azerbaigian 7
EG - Egitto 7
KR - Corea 7
LB - Libano 7
MA - Marocco 7
RO - Romania 7
TN - Tunisia 7
IL - Israele 6
PY - Paraguay 6
AL - Albania 5
AU - Australia 5
CO - Colombia 5
DZ - Algeria 5
KE - Kenya 5
BO - Bolivia 4
JM - Giamaica 4
KZ - Kazakistan 4
LU - Lussemburgo 4
MK - Macedonia 4
PE - Perù 4
CI - Costa d'Avorio 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
KW - Kuwait 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PH - Filippine 3
UY - Uruguay 3
CL - Cile 2
EE - Estonia 2
GH - Ghana 2
HN - Honduras 2
HR - Croazia 2
LA - Repubblica Popolare Democratica del Laos 2
MO - Macao, regione amministrativa speciale della Cina 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
PT - Portogallo 2
SN - Senegal 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BB - Barbados 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
CG - Congo 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
GE - Georgia 1
GM - Gambi 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
MD - Moldavia 1
MM - Myanmar 1
MY - Malesia 1
Totale 17.493
Salva come PNG Salva come JPEG
Città #
Dublin 1.391
Dallas 1.197
Singapore 1.167
Chandler 1.137
Jacksonville 942
Hong Kong 582
Santa Clara 529
Ashburn 428
Boardman 388
New York 283
Izmir 208
Beijing 169
Lawrence 161
Princeton 161
Ann Arbor 151
Los Angeles 151
Moscow 140
Nanjing 125
The Dalles 124
Wilmington 123
L'aquila 99
San Mateo 83
Hefei 79
Munich 79
Columbus 63
Dearborn 63
São Paulo 59
L’Aquila 56
Woodbridge 55
Council Bluffs 54
Helsinki 50
Nanchang 50
Milan 47
Ho Chi Minh City 43
Brussels 41
Tokyo 41
Seattle 37
Shanghai 37
Assago 32
Dong Ket 30
Mountain View 30
Shenyang 30
Stockholm 30
Kunming 29
Brooklyn 28
Des Moines 28
Frankfurt am Main 28
Warsaw 27
Houston 26
Johannesburg 26
Phoenix 26
Hebei 24
Montreal 24
Pescara 23
Tianjin 22
Jinan 21
London 21
Rio de Janeiro 21
Brno 20
Chicago 20
Hanoi 19
Jiaxing 19
Kitzingen 19
Orem 19
San Francisco 19
Verona 19
Atlanta 18
Ankara 17
Cedar Knolls 17
Changsha 17
Denver 17
Falkenstein 17
Lappeenranta 17
Manchester 17
Pune 17
Rome 17
Zhengzhou 17
Amsterdam 16
Guangzhou 16
Jakarta 16
Mexico City 16
Boston 14
New Delhi 14
Turku 14
Chennai 13
Mumbai 13
Belo Horizonte 12
Brasília 12
Ningbo 12
Norwalk 12
Porto Alegre 12
Toronto 12
Washington 12
Bremen 11
Charlotte 11
Hangzhou 11
Poplar 11
Philadelphia 10
Guarulhos 9
Quito 9
Totale 11.749
Salva come PNG Salva come JPEG
Nome #
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 147
FRI0613 H-ferritin and pro-inflammatory cytokines are increased in the bone marrow of adult patients affected by macrophage activation syndrome 144
Role of CD248 molecule as potential regulator of trans-differentiation toward myofibroblasts of perivascular stromal cells in systemic sclerosis patients 138
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis 138
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 136
Unenhanced Cardiac Magnetic Resonance may improve detection and prognostication of an occult heart involvement in asymptomatic patients with systemic sclerosis 136
Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts 131
The role of extracellular matrix components in angiogenesis and fibrosis: Possible implication for Systemic Sclerosis. 130
Prognostic factors of adult onset Still’s disease: analysis of 100 cases in 3 tertiary referral centers 130
The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes 129
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 128
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 127
Evaluating the multivisceral involvement on adult-onset Still’s disease to retrieve imaging-based differences in patients with and without macrophage activation syndrome: results from a single-centre observational study 127
association of pathogenic and regulatory B-cell subsets with clinical and histological features in primary Sjogren's syndrome. 124
Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients. 122
H-ferritin and CD68(+) /H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 122
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 119
Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers 119
Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 113
Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis 113
Cardiovascular disease in primary sjögren’s syndrome 113
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 112
Stromal Cell-derived Factor 1 in Cardiac and Autoimmune Disease 111
Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients. 111
Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients: 1 year prospective single centre study 110
Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations 109
Impaired Cav-1 expression in SSc mesenchymal cells upregulates VEGF signaling: a link between vascular involvement and fibrosis 108
Stem cell therapies for systemic sclerosis 108
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? 107
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies. 107
Short-term effectiveness of guselkumab in psoriatic arthritis patients and axial involvement: results from a real-life multicentre cohort 106
Different operators and histologic techniques in the assessment of germinal center-like structures in primary Sjögren's syndrome minor salivary glands 105
Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort 104
Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies a very early cardiac involvement in systemic sclerosis patients of recent onset 103
Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences 103
Interleukin-9 Overexpression and Th9 Polarization Characterize the Inflamed Gut, the Synovial Tissue, and the Peripheral Blood of Patients With Psoriatic Arthritis 102
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist. 102
Searching for a good model for systemic sclerosis: The molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis 102
Efficacy of inhibition of IL-1 in patients with rheumatoid arthritis and type 2 diabetes mellitus: two case reports and review of the literature. 101
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 101
A comprehensive review on adult onset Still's disease 101
Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features. 101
SENESCENT BONE MARROW DERIVED MESENCHYMAL STEM CELLS (MSC) ARE PRONE TO RECOVER DURING SSC 100
Methotrexate in rheumatoid arthritis: optimizing therapy among different formulations. Current and emerging paradigms 99
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS. 98
Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts 98
Dissecting the clinical heterogeneity of adult-onset Still's disease, results from a multi-dimensional characterisation and stratification 98
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease. 97
Diagnostic and interventional radiology fundamentals of synovial pathology 97
EFFICACY AND SAFETY OF RITUXIMAB TREATMENT IN EARLY PRIMARY SJOGREN'S SYNDROME: A CLINICAL, HISTOLOGICAL AND MOLECULAR STUDY 96
Linking myofibroblast generation and microvascular alteration: The role of CD248 from pathogenesis to therapeutic target (Review) 96
Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander? 96
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities 95
SAT0489 Biologic Therapies and Infections in The Daily Practice: A Study on Historical Cohort from 3 Italian Rheumatologic Units 94
Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis: Results from a cross-sectional study. 94
Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study. 94
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension 94
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 94
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 93
Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study 93
T helper 1 response is correlated with widespread pain, fatigue, sleeping disorders and the quality of life in patients with fibromyalgia and is modulated by hyperbaric oxygen therapy 92
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 92
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 91
Computed Tomography and MR Imaging in Rheumatoid Arthritis 91
Interstitial lung disease in systemic sclerosis: current and future treatment. 91
Decreased Expression of Angiopoetin 1 on Perivascular Mesenchymal Stem Cells from Ssc Patients Induces an Anti Angiogenetic Effect, when Co-cultured with Endothelial Cells 90
The Role of IL-1β in the Bone Loss during Rheumatic Diseases 90
Response to: ‘Correspondence on ‘Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence–radiological differences’ by Ruscitti et al’ by Chen et al 90
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 89
Macrophages with regulatory functions, a possible new therapeutic perspective in autoimmune diseases 89
Myofibroblast Cells Expression of CD248 May Contribute to Exacerbate Microvascular Damage during Systemic Sclerosis 89
Cytokine profile, ferritin and multi-visceral involvement characterize macrophage activation syndrome during adult-onset Still's disease 88
Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study 88
Macrophage activation syndrome in patients affected by adult-onset still disease: Analysis of survival rates and predictive factors in the Gruppo Italiano di Ricerca in reumatologia clinica e sperimentale cohort 88
Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine. 88
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 87
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study. 86
CARDIAC MAGNETIC RESONANCE IMAGING WITH PHARMACOLOGICAL STRESS PERFUSION IN ASYMPTOMATIC PATIENTS WITH SYSTEMIC SCLEROSIS 86
IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes: An observational study 86
ASSESSING PRO-INFLAMMATORY PROPERTIES OF H-FERRITIN BY EX VIVO AND IN VITRO OBSERVATIONS 86
Early assessment of sub-clinical cardiac involvement in systemic sclerosis (SSc) using delayed enhancement cardiac magnetic resonance (CE-MRI). 86
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis 85
The joint involvement in adult onset Still's disease is characterised by a peculiar magnetic resonance imaging and a specific transcriptomic profile 85
Parenchymal lung disease in adult onset Still's disease: An emergent marker of disease severity - Characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients 84
Methotrexate: an old new drug in autoimmune disease. 83
Erratum: Management of adult-onset Still's disease with interleukin-1 inhibitors: Evidence- And consensus-based statements by a panel of Italian experts (Arthritis Res Ther (2019) 21:275 DOI: 10.1186/s13075-019-2021-9) 83
Anakinra effectiveness in refractory polyserositis: An Italian multicenter study 83
Long-term Safety of Rituximab in Primary Sjögren Syndrome: The Experience of a Single Center 82
Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm. 82
The assessment of atlantoaxial joint involvement in patients with rheumatoid arthritis, results from an observational "real-life" study 81
Interleukin (IL)-9/IL-9R axis drives γδ T cells activation in psoriatic arthritis patients 81
Tocilizumab for the treatment of adult-onset Still's disease: Results from a case series 81
Cardiovascular and Metabolic Comorbidities in Rheumatoid Arthritis 80
The Vessels Contribute to Fibrosis in Systemic Sclerosis 80
Glucocorticoids in Rheumatoid Arthritis: The Silent Companion in the Therapeutic Strategy 80
Senescent bone marrow mesenchymal stem cells (BM-MSCS) preserve their immune-regulatory effect on t cells during systemic sclerosis (SSC). 79
Caveolin-1 orchestrates vascular endothelial growth factor (VEGF) signaling control of angiogenesis during systemic sclerosis (SSC) 79
Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still's disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort 79
Cardiometabolic multimorbidity may identify a more severe subset of rheumatoid arthritis, results from a “real-life” study 79
Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with sjogren’s syndrome 78
Totale 10.033
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.594
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.594
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021697 0 0 0 0 0 48 157 21 153 44 206 68
2021/2022803 39 24 153 63 17 12 31 42 66 44 61 251
2022/20233.501 226 193 60 362 209 328 49 217 1.676 21 119 41
2023/20241.043 117 46 69 99 76 325 31 54 22 59 41 104
2024/20254.770 118 79 404 213 624 449 575 308 1.120 222 344 314
2025/20264.309 507 918 823 992 887 182 0 0 0 0 0 0
Totale 17.845